Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus

Applied and Environmental Microbiology

Volumn 66, Issue 6, 2000, Pages 2664-2667

  Parshikov, Igor A ^a   Freeman, James P ^a   Lay Jr , Jackson O ^a   Beger, Richard D ^a   Williams, Anna J ^a   Sutherland, John B ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ENROFLOXACIN;

ARTICLE; DRUG TRANSFORMATION; FUNGUS CULTURE; MUCOR; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; XENOBIOTIC METABOLISM;

ANTI-INFECTIVE AGENTS; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOROQUINOLONES; MAGNETIC RESONANCE SPECTROSCOPY; MUCOR; QUINOLONES;

FUNGI; MUCOR; UMBELOPSIS RAMANNIANA;

EID: 0034130024     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.66.6.2664-2667.2000     Document Type: Article

References (24)

1. Azerad, R. 1999. Microbial models for drug metabolism. Adv. Biochem. Eng. Biotechnol. 63:169-218.
2. Barrow, P. A., M. A. Lovell, G. Szmolleny, and C. K. Murphy. 1998. Effect of enrofloxacin administration on excretion of Salmonella enteritidis by experimentally infected chickens and on quinolone resistance of their Escherichia coli flora. Avian Pathol. 27:586-590.
3. Borner, K., E. Borner, H. Hartwig, and H. Lode. 1990. HPLC of recent quinolone antimicrobials, p. 131-144. In E. Reid and I. D. Wilson (ed.), Analysis for drugs and metabolites, including anti-infective agents. Royal Society of Chemistry, Cambridge, England.
4. Brown, S. A. 1996. Fluoroquinolones in animal health. J. Vet. Pharmacol. Ther. 19:1-14.
5. Cerniglia, C. E., E. B. Hansen, Jr., K. J. Lambert, W. A. Korfmacher, and D. W. Miller. 1988. Fungal transformations of antihistamines: metabolism of methapyrilene, thenyldiamine and tripelennamine to N-oxide and N-demethylated derivatives. Xenobiotica 18:301-312.
6. Chen, Y., J. P. N. Rosazza, C. P. Reese, H.-Y. Chang, M. A. Nowakowski, and J. P. Kiplinger. 1997. Microbial models of soil metabolism: biotransformations of danofloxacin. J. Ind. Microbiol. Biotechnol. 19:378-384.
7. Coutts, R. T., B. C. Foster, and F. M. Pasutto. 1981. Fungal metabolism of (-)-deprenyl and pargyline. Life Sci. 29:1951-1958.
8. Griffin, D. M. 1972. Ecology of soil fungi. Chapman and Hall, London, England.
9. Hansen, E. B., Jr., C. E. Cerniglia, W. A. Korfmacher, D. W. Miller, and R. H. Heflich. 1987. Microbial transformation of the antihistamine pyrilamine maleate. Formation of potential mammalian metabolites. Drug Metab. Dispos. 15:97-106.
10. Hooper, D. C., and J. S. Wolfson (ed.). 1993. Quinolone antimicrobial agents, 2nd ed. American Society for Microbiology, Washington, D.C.
11. Lode, H., G. Höffken, C. Prinzing, P. Glatzel, R. Wiley, P. Olschewski, B. Sievers, D. Reimnitz, K. Borner, and P. Koeppe. 1987. Comparative pharmacokinetics of new quinolones. Drugs 34(Suppl. 1):21-25.
12. Martens, R., H.-G. Wetzstein, F. Zadrazil, M. Capelari, P. Hoffmann, and N. Schmeer. 1996. Degradation of the fluoroquinolone enrofloxacin by woodrotting fungi. Appl. Environ. Microbiol. 62:4206-4209.
13. Medders, W. M., R. E. Wooley, P. S. Gibbs, E. B. Shotts, and J. Brown. 1998. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones. Avian Dis. 42:146-153.
14. Modyanova, L. V., M. R. Duduchava, N. F. Piskunkova, G. V. Grishina, P. B. Terentyev, and I. A. Parshikov. 1999. Microbial transformations of piperidine and pyridine derivatives. Khim. Geterotsikl. Soed. 1999:649-655. (In Russian.)
15. Nakamura, R., T. Yamaguchi, Y. Sekine, and M. Hashimoto. 1983. Determination of a new antibacterial agent (AT-2266) and its metabolites in plasma and urine by high-performance liquid chromatography. J. Chromatogr. 278:321-328.
16. Nakashima, M., M. Kanamaru, T. Uematsu, A. Takiguchi, A. Mizuno, T. Itaya, F. Kawahara, T. Ooie, S. Saito, H. Uchida, and K. Masuzawa. 1988. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers. J. Antimicrob. Chemother 22(Suppl. D):133-144.
17. Parshikov, I. A., J. P. Freeman, J. O. Lay, Jr., R. D. Beger, A. J. Williams, and J. B. Sutherland. 1999. Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol. Lett. 177:131-135.
18. Parshikov, I. A., J. P. Freeman, A. J. Williams, J. D. Moody, and J. B. Sutherland. 1999. Biotransformation of N-acetylphenothiazine by fungi. Appl. Microbiol. Biotechnol. 52:553-557.
19. Sewell, G. J., C. J. Soper, and R. T. Parfitt. 1984. The screening of some microorganisms for their ability to N-dealkylate drug molecules. Appl. Microbiol. Biotechnol. 19:247-251.
20. Sudo, K., O. Okazaki, M. Tsumura, and H. Tachizawa. 1986. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys. Xenobiotica 16:725-732.
21. Tyczkowska, K., K. M. Hedeen, D. P. Aucoin, and A. L. Aronson. 1989. High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic tissue. J. Chromatogr. 493:337-346.
22. Wetzstein, H.-G., N. Schmeer, and W. Karl. 1997. Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites. Appl. Environ. Microbiol. 63:4272-4281.
23. Wetzstein, H.-G., M. Stadler, H.-V. Tichy, A. Dalhoff, and W. Karl. 1999. Degradation of ciprofloxacin by basidiomycetes and identification of metabolites generated by the brown rot fungus Gloeophyllum striatum. Appl. Environ. Microbiol. 65:1556-1563.
24. Zeiler, H.-J., U. Petersen, W. Gau, and H. J. Ploschke. 1987. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay. Arzneim. Forschung/Drug Res. 37:131-134.